Terms: = Ovarian cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Treatment
284 results:
1. Honokiol induces ferroptosis in ovarian cancer cells through the regulation of YAP by OTUB2.
Liu F; Zhang Y; Xia X; Han J; Cao L
J Obstet Gynaecol Res; 2024 May; 50(5):864-872. PubMed ID: 38480480
[TBL] [Abstract] [Full Text] [Related]
2. ZSWIM4 inhibition improves chemosensitivity in epithelial ovarian cancer cells by suppressing intracellular glycine biosynthesis.
Gong K; Huang Y; Zheng Y; Hao W; Shi K
J Transl Med; 2024 Feb; 22(1):192. PubMed ID: 38383406
[TBL] [Abstract] [Full Text] [Related]
3. 8-hydroxyquinoline-N-oxide copper(II)- and zinc(II)-phenanthroline and bipyridine coordination compounds: Design, synthesis, structures, and antitumor evaluation.
Du LQ; Zeng CJ; Mo DY; Qin QP; Tan MX; Liang H
J Inorg Biochem; 2024 Feb; 251():112443. PubMed ID: 38100902
[TBL] [Abstract] [Full Text] [Related]
4. Insulin-like growth factor 2 mRNA-binding protein 2 is a therapeutic target in ovarian cancer.
Yuan J; Li X; Wang F; Liu H; Guan W; Xu G
Exp Biol Med (Maywood); 2023 Dec; 248(23):2198-2209. PubMed ID: 38084732
[TBL] [Abstract] [Full Text] [Related]
5. Baicalein improves the chemoresistance of ovarian cancer through regulation of CirSLC7A6.
Li S; Yi Z; Li M; Zhu Z
J Ovarian Res; 2023 Nov; 16(1):212. PubMed ID: 37940982
[TBL] [Abstract] [Full Text] [Related]
6. Effect of alpha lipoic acid on epithelial mesenchymal transition in SKOV-3 cells.
Önder E; Çil N; Seçme M; Mete GA
Gene; 2024 Jan; 892():147880. PubMed ID: 37813206
[TBL] [Abstract] [Full Text] [Related]
7. Extraovarian Dysgerminoma Involving the Uterine Cervix: A Rare Case Report With Literature Review.
Yoshino Y; Yanai S; Sawada M; Sakate S; Kanno K; Hada T; Ueda T; Tabata T; Omori M; Andou M
Int J Gynecol Pathol; 2023 Nov; 42(6):544-549. PubMed ID: 37668336
[TBL] [Abstract] [Full Text] [Related]
8. REG3A promotes proliferation and DDP resistance of ovarian cancer cells by activating the PI3K/Akt signaling pathway.
Jiang L; Liu Y; Liu M; Zheng Y; Chen L; Shan F; Ji J; Cao Y; Kai H; Kang X
Environ Toxicol; 2024 Jan; 39(1):85-96. PubMed ID: 37665173
[TBL] [Abstract] [Full Text] [Related]
9. cancer Stem Cell Markers-Clinical Relevance and Prognostic Value in High-Grade Serous ovarian cancer (HGSOC) Based on The cancer Genome Atlas Analysis.
Iżycka N; Zaborowski MP; Ciecierski Ł; Jaz K; Szubert S; Miedziarek C; Rezler M; Piątek-Bajan K; Synakiewicz A; Jankowska A; Figlerowicz M; Sterzyńska K; Nowak-Markwitz E
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628927
[TBL] [Abstract] [Full Text] [Related]
10. Raptor couples mTORC1 and ERK1/2 inhibition by cardamonin with oxidative stress induction in ovarian cancer cells.
Zhu Y; Wang S; Niu P; Chen H; Zhou J; Jiang L; Li D; Shi D
PeerJ; 2023; 11():e15498. PubMed ID: 37304865
[TBL] [Abstract] [Full Text] [Related]
11. LncRNA OTUD6B-AS1 overexpression promoted GPX4-mediated ferroptosis to suppress radioresistance in colorectal cancer.
Zhang Z; Ye B; Lin Y; Liu W; Deng J; Ji W
Clin Transl Oncol; 2023 Nov; 25(11):3217-3229. PubMed ID: 37184781
[TBL] [Abstract] [Full Text] [Related]
12. PDLIM2 can inactivate the TGF-β/Smad pathway to inhibit the malignant behavior of ovarian cancer cells.
Lv W; Guo H; Wang J; Ma R; Niu L; Shang Y
Cell Biochem Funct; 2023 Jul; 41(5):542-552. PubMed ID: 37170668
[TBL] [Abstract] [Full Text] [Related]
13. Promotive role of eukaryotic translation initiation factor 4A isoform 3 in ovarian cancer cell growth and aerobic glycolysis through the pyruvate dehydrogenase kinase 4 signaling.
Bai SS; Yan LW; Liu CH
Kaohsiung J Med Sci; 2023 May; 39(5):478-488. PubMed ID: 37098796
[TBL] [Abstract] [Full Text] [Related]
14. De novo myeloid sarcoma mimicking gynecological tumors: a retrospective case series of eight patients.
Gu Y; Zheng H; Mo S; Guo T; Chen L; Yang J; Xiang Y
BMC Womens Health; 2023 Mar; 23(1):141. PubMed ID: 36978050
[TBL] [Abstract] [Full Text] [Related]
15. Eliciting effective tumor immunity against ovarian cancer by cancer stem cell vaccination.
Xu H; Zhao F; Wu D; Zhang Y; Bao X; Shi F; Cai Y; Dou J
Biomed Pharmacother; 2023 May; 161():114547. PubMed ID: 36933377
[TBL] [Abstract] [Full Text] [Related]
16. Improved detection of homologous recombination deficiency in Chinese patients with ovarian cancer: a novel non-exonic single-nucleotide polymorphism-based next-generation sequencing panel.
Wei B; Zheng J; Jiang C; Zhang H; Zhang M; Cheng T; Li J; Wang Z; Deng L; Wang L; Xia Q; Ma J
Mol Oncol; 2023 Aug; 17(8):1666-1677. PubMed ID: 36852736
[TBL] [Abstract] [Full Text] [Related]
17. Differential effects of the LncRNA RNF157-AS1 on epithelial ovarian cancer cells through suppression of DIRAS3- and ULK1-mediated autophagy.
Xu P; Xu S; Pan H; Dai C; Xu Y; Wang L; Cong Y; Zhang H; Cao J; Ge L; Jia X
Cell Death Dis; 2023 Feb; 14(2):140. PubMed ID: 36805591
[TBL] [Abstract] [Full Text] [Related]
18. Shikonin and cisplatin synergistically overcome cisplatin resistance of ovarian cancer by inducing ferroptosis via upregulation of HMOX1 to promote Fe
Ni M; Zhou J; Zhu Z; Xu Q; Yin Z; Wang Y; Zheng Z; Zhao H
Phytomedicine; 2023 Apr; 112():154701. PubMed ID: 36773431
[TBL] [Abstract] [Full Text] [Related]
19. An angiogenic tumor phenotype predicts poor prognosis in ovarian cancer.
Wieser V; Tsibulak I; Reimer DU; Zeimet AG; Fiegl H; Hackl H; Marth C
Gynecol Oncol; 2023 Mar; 170():290-299. PubMed ID: 36758419
[TBL] [Abstract] [Full Text] [Related]
20. Knockdown of circ-PIP5K1A overcomes resistance to cisplatin in ovarian cancer by miR-942-5p/NFIB axis.
Sheng H; Wang X
Anticancer Drugs; 2023 Feb; 34(2):214-226. PubMed ID: 36730637
[TBL] [Abstract] [Full Text] [Related]
[Next]
